Categories: News

Holy Name Medical Center Launches One-Stick Hospitalization as New Inpatient Standard of Care

First in New Jersey to standardize on needle-free blood collection procedure, Holy Name builds on its reputation as a technology and treatment innovator; demonstrates power of virtual training amidst COVID-19 era

TEANECK, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) — Holy Name Medical Center today announced that it is the first hospital in New Jersey among a growing number of health systems nationwide to offer needle-free blood draws for inpatients using the PIVO™ device from vascular access technology pioneer Velano Vascular. As part of this effort, Holy Name is deploying a new telepresence technology, also provided by Velano, to train staff virtually on the PIVO procedure in accordance with COVID-19 safety protocols.

By adopting this new standard of care known as One-Stick Hospitalization, Holy Name is again leading the charge for better medicine and building on a number of other recent landmark achievements. With this procedure, Holy Name staff can extract high quality blood draws easily and humanely from patients’ indwelling IV lines without requiring additional needle sticks, resulting in a safer, better experience.

“Holy Name is proudly on the leading edge of today’s most innovative clinical practices, and we remain committed to enhancing both the patient and staff experience by removing the needle from blood collection,” said Adam Jarrett, MD, EVP and chief medical officer at Holy Name. “The One-Stick Hospitalization movement transforms a universally dreaded and unpleasant experience into a patient satisfier – improving the standard, quality, and cost of care for everyone involved.”

To train staff on proper use of Velano’s technology, Holy Name has deployed Velano Vascular’s virtual training platform. The company’s remotely piloted trainers enable Holy Name staff to receive real-time, bedside training from Velano nurse educators while limiting in-person interaction and exposure during the pandemic.

“The pandemic is actively changing the way we practice medicine and will undoubtedly move us to a place where telepresence for new product and practice training and engagement is a routine part of healthcare,” said Michele Acito, DNP, NP, NE-BC, EVP and chief nursing officer at Holy Name Medical Center. “We are excited to be one of the first hospitals in the country to embrace virtual training as part of adopting this new vascular access practice that touches every single one of our inpatients.”

Learn more about how Holy Name is ranked among the best hospitals in the nation for patient care, clinical performance and workplace excellence at holyname.org.

About Holy Name Medical Center
Holy Name Medical Center is a fully accredited, not-for-profit healthcare facility based in Teaneck, New Jersey, with off-site locations throughout Bergen County.  Founded and sponsored by the Sisters of St. Joseph of Peace in 1925, the comprehensive 361-bed medical center offers leading-edge medical practice and technology administered in an environment rooted in a tradition of compassion and respect for every patient. Holy Name provides high quality health care across a continuum that encompasses education, prevention, early intervention, comprehensive treatment options, rehabilitation and wellness maintenance.

Press Contact:
Jessica Griffin
Director, Public Relations
Holy Name Medical Center
C: 201.543.4935

Staff

Recent Posts

Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)

Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite"…

2 hours ago

Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design

'Beyond Structure, Predicting Function' SHANGHAI, Dec. 25, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co.,…

9 hours ago

Casect Launches AI-Enhanced Case Log Platform for Surgeons

SHERIDAN, Wyo., Dec 25, 2024 /PRNewswire/ -- Casect, LLC, a medical education technology company, announces…

15 hours ago

CorVel Announces Effectiveness of Three-For-One Forward Stock Split

FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced…

24 hours ago

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be…

24 hours ago